APA (7th ed.) Citation

Y, S., Z, Y., S, L., L, W., Y, Z., Y, Z., . . . L, X. (2024). Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. British journal of cancer, 131(10), 1683. https://doi.org/10.1038/s41416-024-02863-9

Chicago Style (17th ed.) Citation

Y, Sun, et al. "Losartan Rewires the Tumor-immune Microenvironment and Suppresses IGF-1 to Overcome Resistance to Chemo-immunotherapy in Ovarian Cancer." British Journal of Cancer 131, no. 10 (2024): 1683. https://doi.org/10.1038/s41416-024-02863-9.

MLA (9th ed.) Citation

Y, Sun, et al. "Losartan Rewires the Tumor-immune Microenvironment and Suppresses IGF-1 to Overcome Resistance to Chemo-immunotherapy in Ovarian Cancer." British Journal of Cancer, vol. 131, no. 10, 2024, p. 1683, https://doi.org/10.1038/s41416-024-02863-9.